HCN3 Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">HCN3 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>HCN3</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>HCN3</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=HCN3" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
HCN3 (hyperpolarization-activated cyclic nucleotide-gated channel 3) is a voltage-gated cation channel that contributes to the `Ih/If` current family and helps regulate rhythmic firing, membrane potential recovery, and temporal filtering in excitable circuits.[@biel2009][@pape1996] Compared with HCN1 and HCN2, HCN3 has been less extensively characterized, but available data indicate distinctive gating and regulatory behavior that can influence thalamic, limbic, and dopaminergic-network dynamics.[@biel2009][@caoehlker2013][@fagerberg2014]
HCN3 is not a dominant single-gene cause of common neurodegenerative syndromes, yet HCN-channel dysregulation maps onto core disease mechanisms including network hyperexcitability, mitochondrial stress, and impaired adaptive plasticity.[@heneka2014][@styr2018][@santoro2020]
Molecular Architecture and Channel Function
...
HCN3 Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">HCN3 Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>HCN3</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>HCN3</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=HCN3" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
HCN3 (hyperpolarization-activated cyclic nucleotide-gated channel 3) is a voltage-gated cation channel that contributes to the `Ih/If` current family and helps regulate rhythmic firing, membrane potential recovery, and temporal filtering in excitable circuits.[@biel2009][@pape1996] Compared with HCN1 and HCN2, HCN3 has been less extensively characterized, but available data indicate distinctive gating and regulatory behavior that can influence thalamic, limbic, and dopaminergic-network dynamics.[@biel2009][@caoehlker2013][@fagerberg2014]
HCN3 is not a dominant single-gene cause of common neurodegenerative syndromes, yet HCN-channel dysregulation maps onto core disease mechanisms including network hyperexcitability, mitochondrial stress, and impaired adaptive plasticity.[@heneka2014][@styr2018][@santoro2020]
Molecular Architecture and Channel Function
HCN channels are tetramers with six transmembrane segments per subunit and a cyclic nucleotide-binding domain (CNBD) in the C-terminus.[@biel2009][@pape1996] They open on hyperpolarization (opposite to many voltage-gated channels) and carry mixed Na+/K+ inward current that depolarizes membrane potential toward threshold.[@biel2009][@pape1996]
Key HCN3-relevant functional principles:
Rebound control after inhibitory input.
Oscillation shaping in rhythm-generating circuits.
Subthreshold integration in dendrites and soma.
Neuromodulator coupling through cAMP-dependent gating shifts.[@biel2009][@caoehlker2013]HCN3 is additionally regulated by interacting proteins and membrane lipids, and can display slower gating kinetics in some cellular contexts.[@caoehlker2013][@fagerberg2014]
Expression and Circuit-Level Roles
HCN3 transcripts and protein are detected in brain regions involved in arousal, salience, and sensorimotor integration, with signal also seen in non-neural tissues.[@fagerberg2014][@chang2019] At network level, `Ih` conductances set resonance properties and timing windows for synaptic integration; disruption can produce either hypo-responsiveness or unstable burst propensity depending on circuit state.[@pape1996][@styr2018]
Experimental literature supports HCN3 participation in:
- thalamic rhythmic activity,
- dopaminergic system modulation,
- state-dependent oscillation control.[@caoehlker2013][@santoro2020][@ying2011]
Neurodegeneration-Relevant Mechanistic Interpretation
Persistent alterations in HCN-mediated conductance can increase spiking inefficiency and ATP demand. In [neurons](/entities/neurons) already burdened by proteostatic and mitochondrial stress, this may lower resilience thresholds.[@heneka2014][@styr2018]
Interaction with synaptic dysfunction
`Ih` remodeling alters temporal summation and can destabilize circuit compensation. In AD/PD/ALS-like settings where synapses are already compromised, this may accelerate functional decline even without primary structural lesions in HCN3 itself.[@styr2018][@frere2018]
Cross-talk with inflammatory states
Neuroinflammatory signaling can alter channel expression and trafficking. HCN-channel changes may then reinforce dysrhythmic activity and maladaptive plasticity, creating a feed-forward progression loop.[@heneka2014][@martin2010]
Disease Associations and Evidence Strength
Current human evidence for direct pathogenic HCN3 variants in major neurodegenerative diseases is limited. The strongest evidence currently supports a modifier model:
- HCN3 contributes to excitability setpoints.
- Excitability state influences disease expression and symptom burden.
- HCN-family modulation can be therapeutically meaningful in selected contexts.[@styr2018][@santoro2020][@frere2018]
This framing is useful for biomarker-guided therapeutics even when monogenic causality is weak.
Therapeutic Implications
Most translational work targets HCN-family physiology rather than HCN3 alone. Key priorities are:
Defining disease-stage windows where `Ih` normalization improves network efficiency.
Avoiding over-suppression that worsens cognition or mood circuits.
Using electrophysiologic biomarkers to enrich for responder phenotypes.[@santoro2020][@frere2018]Combination strategies that pair excitability modulation with mitochondrial or anti-inflammatory interventions may have better biological plausibility than single-pathway monotherapy in chronic neurodegeneration.[@heneka2014][@martin2010]
Open Questions
- Which neuronal subtypes show consistent HCN3 remodeling in human AD/PD/ALS tissue?
- Are there reproducible HCN3-linked EEG or MEG signatures that track progression?
- Can iPSC-derived neuron systems isolate HCN3-specific effects from broader HCN-family compensation?
See Also
- [HCN3](/genes/hcn3)
- [KCNIP1 Protein](/proteins/kcnip1-protein)
- [Excitotoxicity](/mechanisms/excitotoxicity)
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
- [Neuroinflammation](/mechanisms/neuroinflammation)
External Links
- [UniProt: Q9P1Z3](https://www.uniprot.org/uniprotkb/Q9P1Z3)
- [NCBI Gene: HCN3](https://www.ncbi.nlm.nih.gov/gene/57669)
- [IUPHAR HCN Family](https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=73)
References
[Biel M, Wahl-Schott C, Michalakis S, Zong X, Hyperpolarization-activated cation channels: from genes to function (2009)](https://pubmed.ncbi.nlm.nih.gov/17611229/)
[Pape HC, Queer current and pacemaker: the hyperpolarization-activated cation current in neurons (1996)](https://pubmed.ncbi.nlm.nih.gov/10601394/)
[Cao-Ehlker X, Zong X, Hammelmann V, et al, Up-regulation of hyperpolarization-activated cyclic nucleotide-gated channel 3 (HCN3) by specific interaction with K+ channel tetramerization domain-containing protein 3 (KCTD3) (2013)](https://pubmed.ncbi.nlm.nih.gov/23382386/)
[Fagerberg L, Hallstrom BM, Oksvold P, et al, Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics (2014)](https://pubmed.ncbi.nlm.nih.gov/24309898/)
[Heneka MT, Kummer MP, Latz E, Innate immune activation in neurodegenerative disease (2014)](https://pubmed.ncbi.nlm.nih.gov/25083192/)
[Styr B, Slutsky I, Imbalance between firing homeostasis and synaptic plasticity drives early-phase Alzheimer's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/27477310/)
[Santoro B, Shah MM, Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels as Drug Targets for Neurological Disorders (2020)](https://pubmed.ncbi.nlm.nih.gov/31914897/)
[Chang X, Wang J, Jiang H, et al, Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels: An Emerging Role in Neurodegenerative Diseases (2019)](https://pubmed.ncbi.nlm.nih.gov/31231190/)
[Ying SW, Tibbs GR, Picollo A, et al, PIP2-mediated HCN3 channel gating is crucial for rhythmic burst firing in thalamic intergeniculate leaflet neurons (2011)](https://pubmed.ncbi.nlm.nih.gov/21753018/)
[Frere S, Slutsky I, Alzheimer's disease: from firing instability to homeostasis network collapse (2018)](https://pubmed.ncbi.nlm.nih.gov/30097519/)
[Martin LJ, Mitochondrial and cell death mechanisms in neurodegenerative diseases (2010)](https://pubmed.ncbi.nlm.nih.gov/18724929/)